This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medical Discovery Partners LLC. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Sarah K Olken
Introduction
Sarah K Olken is a notable inventor based in Belmont, MA (US). She has made significant strides in the field of medical technology, particularly in the separation of rare cell subpopulations from blood. Her work has the potential to enhance diagnostic and therapeutic approaches in various medical conditions.
Latest Patents
Sarah K Olken holds a patent for a method titled "Method for enriching rare cell subpopulations from blood." This innovative technique describes an antigen-dependent negative selection blood cell separation method. The method allows for the separation of rare circulating epithelial cells from blood by depleting erythrocytes from a blood sample. Erythrocytes are depleted through agglutination, utilizing an agglutinating agent such as an anti-glycophorin A or glycophorin B antibody. This is crucial as glycophorin A or B is present on erythrocytes and not on the desired epithelial cells. With regular mixing, the rare circulating epithelial cells do not become entrapped in the red cell agglutinate.
Career Highlights
Sarah is associated with Medical Discovery Partners LLC, where she continues to contribute to advancements in medical research and technology. Her innovative approach to blood cell separation showcases her commitment to improving medical diagnostics.
Collaborations
Some of her notable coworkers include Seshi R Sompuram and Steven A Bogen. Their collaborative efforts contribute to the ongoing research and development in the field.
Conclusion
Sarah K Olken's contributions to medical technology through her innovative patent demonstrate her expertise and dedication to advancing healthcare solutions. Her work in enriching rare cell subpopulations from blood is a testament to her impact in the field.